The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Moves to Reevaluate Several Peptides American Med Spa Association FDA Peptide Update: Category 2 Removals Explained Is BPC 157 Legal? Understanding Its Status and Implications FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure